Drugs for the treatment of patients with advanced or recurrent cancer that are refractory or intolerant to standard chemotherapy and cannot be curatively resected

• 1. 用于对标准化疗不反应或不耐受且无法根治性切除的进行性或复发性癌患者的治疗的药物 [P] . 中国专利： CN110430885A . 2019-11-08
• 2. 一种治疗TP53突变的晚期难治性实体瘤的药物及应用 [P] . 中国专利： CN112316149A . 2021-02-05
• 3. Drugs for the treatment of patients with unresectable advanced or recurrent cancer who are refractory or intolerant to standard chemotherapy [P] . 日本专利： JP6704594B2 . 2020.06.03
• 4. MEDICINE FOR TREATING ADVANCED OR RECURRENT CANCER PATIENT BEING NON-RESPONSIVE OR NON-TOLERANT TO STANDARD CHEMOTHERAPY AND INCURABLE AND UNRESECTABLE [P] . 美国专利： US2020268703A1 . 2020-08-27

  机译： 治疗高级或复发性癌症患者的药物对标准化学治疗无反应或不耐受，且可治愈且无法治疗

• 5. MEDICINE FOR TREATING ADVANCED OR RECURRENT CANCER PATIENT BEING NON-RESPONSIVE OR NON-TOLERANT TO STANDARD CHEMOTHERAPY AND INCURABLE AND UNRESECTABLE [P] . 世界知识产权组织专利： WO2018174053A1 . 2018-09-27

  机译： 治疗高级或复发性癌症患者的药物对标准化学治疗无反应或不耐受，且可治愈且无法治疗

• 1. A phase Ⅰ study of nimotuzumab plus docetaxel in chemotherapy-refractory/resistant patients with advanced non-small-cell lung cancer [J] . Jun Zhao, Minglei Zhuo, Zhijie Wang, 中国癌症研究（英文版） . 2016,第001期
• 2. Effect of Neoadjuvant Chemotherapy Treatment on Prognosis of Patients with Advanced Gastric Cancer:a Retrospective Study [J] . Shu-bo Tian, Jian-chun Yu, Wei-ming Kang, 中国医学科学杂志（英文版） . 2015,第002期
• 3. A randomized phase III study of hepatic arterial infusion chemotherapy with 5-fluorouracil and subsequent systemic chemotherapy versus systemic chemotherapy alone for colorectal cancer patients with curatively resected liver metastases (Japanese Foundation for Multidisciplinary Treatment of Cancer 32) [J] . Mitsuo Kusano, Toru Aoyama, Koji Okabayashi, Journal of Cancer Research and Therapeutics . 2018,第10期
• 4. A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2) [J] . Kato Ken, Satoh Taroh, Muro Kei, Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association . 2019,第2期
• 5. Safety and feasibility of adjuvant chemotherapy with S-1 for Korean patients with curatively resected advanced gastric cancer [J] . JeongJ.H., RyuM.-H., RyooB.-Y., Cancer chemotherapy and pharmacology. . 2012,第4期
• 6. Effects of Weekly Paclitaxel as a Second-Iine Anticancer Chemotherapy for Patients with Advanced and Recurrent Gastric Carcinoma [C] . Y. Sakurai, I. Yoshida, T. Masui, International Gastric Cancer Congress . 2005
• 7. Treatment Patterns and Cost-Effectiveness of Chemotherapy Treatments among Advanced Gastric Cancer Patients [D] . Haag, Austin Jade. 2017
• 8. A subanalysis of Japanese patients in a randomized double-blind placebo-controlled phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to or intolerant of at least two previous chemotherapy regimens (ONO-4538-12 ATTRACTION-2) [O] . Ken Kato, Taroh Satoh, Kei Muro, -1
• 9. A retrospective chart review of drug treatment patterns and clinical outcomes among patients with metastatic or recurrent soft tissue sarcoma refractory to one or more prior chemotherapy treatments [O] . Michael J Wagner, Leo Ismaila Amodu, Mei Sheng Duh, 2015

• 1. Oral chemotherapy for second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer [J] . Se Jun Park ,Hyunho Kim ,Kabsoo Shin . 世界胃肠肿瘤学杂志：英文版（电子版） . 2019,第11期
• 2. Effect of Fucoidan Dietary Supplement on the Chemotherapy Treatment of Patients with Unresectable Advanced Gastric Cancer [J] . Masahide Ikeguchi ,Hiroaki Saito ,Yasunari Miki . 癌症治疗（英文） . 2015,第11期
• 3. Prognostic role of the ABO blood types in Chinese patients with curatively resected non-small cell lung cancer:a retrospective analysis of 1601 cases at a single cancer center [J] . Ning Li ,Miao Xu ,Chao-Feng Li . 癌症 . 2015,第10期
• 4. 吉西他滨联合化疗治疗难治复发性T细胞性非霍奇金淋巴瘤临床观察 [C] . 刘丹 ,谭获 ,黄振倩 . 第三届中国医师协会血液医师论坛 . 2009
• 5. 局部晚期宫颈癌(IB2和IIA2期)新辅助化疗+根治术、直接根治术与同步放化疗三种治疗方式的治疗过程、不良反应及预后的相关比较研究 [A] . 李丹丹 . 2018